- Home
- KOD vs STIM Comparison
KOD vs STIM Comparison
Compare KOD & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- STIM
- Stock Information
- Founded
- KOD 2009
- STIM 2003
- Country
- KOD United States
- STIM United States
- Employees
- KOD N/A
- STIM N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- STIM Medical/Dental Instruments
- Sector
- KOD Health Care
- STIM Health Care
- Exchange
- KOD Nasdaq
- STIM Nasdaq
- Market Cap
- KOD 198.4M
- STIM 221.8M
- IPO Year
- KOD 2018
- STIM 2018
- Fundamental
- Price
- KOD $8.84
- STIM $4.49
- Analyst Decision
- KOD Hold
- STIM Buy
- Analyst Count
- KOD 3
- STIM 4
- Target Price
- KOD $9.00
- STIM $6.00
- AVG Volume (30 Days)
- KOD 549.8K
- STIM 1.1M
- Earning Date
- KOD 08-13-2025
- STIM 08-05-2025
- Dividend Yield
- KOD N/A
- STIM N/A
- EPS Growth
- KOD N/A
- STIM N/A
- EPS
- KOD N/A
- STIM N/A
- Revenue
- KOD N/A
- STIM $89,448,000.00
- Revenue This Year
- KOD N/A
- STIM $105.22
- Revenue Next Year
- KOD N/A
- STIM $11.89
- P/E Ratio
- KOD N/A
- STIM N/A
- Revenue Growth
- KOD N/A
- STIM 22.16
- 52 Week Low
- KOD $1.92
- STIM $0.52
- 52 Week High
- KOD $11.60
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- KOD 84.50
- STIM 70.76
- Support Level
- KOD $5.00
- STIM $3.62
- Resistance Level
- KOD $5.73
- STIM $4.65
- Average True Range (ATR)
- KOD 0.70
- STIM 0.28
- MACD
- KOD 0.42
- STIM 0.12
- Stochastic Oscillator
- KOD 99.61
- STIM 88.01
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.